Delaware Bioscience Association President Michael Fleming takes a 30,000 foot-view of innovation and the First State's role as a catalyst.
Delaware Business Times Editor Katie Tabeling looks at the challenges many bioscience start-up companies face that seek to push boundaries in medical and scientific research.
Four experts in the bioscience industry said that that raising capital has faced significant headwinds in recent years. but there is optimism.
The biosciences climate in Delaware is robust and making a significant difference in finding cures for the most aggressive diseases and conditions. Eighty percent of the U.S. pharmaceuticals industry is […]
For 20 years, B&W Tek has developed and marketed products that provide light-generation services to researchers and other clinicians. The company has offices in five countries and 70 distributors worldwide. […]
Premier Digital Partners
© 2024 Delaware Business Times
